Our results illustrated this phenomenon fairly well, as decreasing FEV1% predicted, but not GOLD stages, was associated with MMP-9 and MMP-9/TIMP-1 ratio among subjects with COPD. The gene discussed is MMP9; the disease is chronic obstructive pulmonary disease.